Hidradenitis suppurativa (HS) is a chronic inflammatory disease that is disproportionately prevalent among women of reproductive age.1 Inflammatory conditions such as systemic vasculitis and systemic lupus erythematosus during pregnancy have adverse outcomes, including increased preterm birth and pregnancy loss.2 Yet, few data regarding the implications of HS for pregnancy are available, limiting the ability to counsel and deliver care to women with HS.3 Results of this survey study characterize the perspectives and practice gaps related to pregnancy and childbirth among female patients with HS.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Adelekun AA, Villa NM, Hsiao JL, Micheletti RG. Pregnancy in Hidradenitis Suppurativa—Patient Perspectives and Practice Gaps. JAMA Dermatol. Published online January 13, 2021. doi:10.1001/jamadermatol.2020.5162
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: